In the wake of evidence that essential neurogenic processes might involve aspects of DNA rearrangement, recent discoveries about the unusual arrangement of genes encoding neuronal adhesion molecules known as protocadherins are very intriguing. But is this just a coincidence? "Curiouser and curiouser!" Alice's reaction to the strange events encountered during her Adventures in Wonderland is being echoed by biologists puzzling over recent tantalizing hints that somatic DNA rearrangement -of a kind well-known to be of fundamental importance in the immune system -may operate in the nervous system. The first of these hints, reviewed recently in these pages [1] , came from close examination of mutant mice deficient for components of the enzymatic machinery essential for the DNA rearrangements that create the genes for mature antigen receptors of B and T lymphocytes. These mutant mice, deficient for either DNA ligase IV [2, 3] or its dimerization partner XRCC4 [2], were found to exhibit a striking increase in the death of very young neurons and neuroblasts. This phenotype has subsequently been found to be shared by mice deficient in other components of the so-called 'non-homologous end-joining system' (F. Alt, personal communication).
These results have excited interest in the possibility that some form of somatic DNA rearrangement might be associated with the development of the nervous system, although this is certainly not the only explanation for the observations. If DNA rearrangement does turn out to be important in the nervous system, what are the relevant genetic targets? Such a target is, of course, likely to be expressed in the nervous system, probably in specific subpopulations of neurons; by analogy with the antigenreceptor genes, it is likely to consist of a large gene family, and the genes might well encode cell-surface molecules [4] . An attractive candidate target that fits these criteria has been identified. This is the family of genes encoding the protocadherins [5] [6] [7] , a subfamily of the cadherin adhesion molecules. The protocadherin genes in humans have recently been found [8] to have a genomic structure that is rather suggestive of a locus that might undergo DNA rearrangements.
Protocadherins and cadherin-related neuronal receptors
The protocadherins are structurally related to the betterknown 'classical cadherins' [9] (Figure 1 ). These are cell adhesion molecules that engage in calcium-dependent homophilic interactions, and have been shown to have important roles in development. They are oriented in the membrane with the amino-terminus outside the cell; the amino-terminal signal peptide is followed by a characteristic grouping of five tandem repeats, known as 'ectodomains', a single transmembrane region, and then an intracellular carboxy-terminal region that interacts with the cytoskeleton. Protocadherins have a similar extracellular organization, with five or six ectodomains, but they clearly differ in the cytoplasmic region.
A distinct subgroup related to the protocadherins consists of the cadherin-related neuronal receptors [7] . These all have six ectodomains -the first of which has an unusual RGD (putative integrin-binding) motif -and a distinctive cytoplasmic region that includes a characteristic lysine-rich segment. Notably, the cadherin-related neuronal receptors and some protocadherins show enriched or specific expression in the nervous system [7, 10] ; and like some of the classical cadherin subtypes, the cadherinrelated neuronal receptors can also show differential expression in subpopulations of synapses [11] .
The Cnr genes that encode the cadherin-related neuronal receptors were first cloned on the basis of their protein products' ability to bind to the tyrosine kinase Fyn, a molecule that has been shown to function in both the immune system -where it is involved in signaling from the T-cell receptor [12] -and the nervous system -fyn deletion has been associated with behavioral deficits [13] . The mouse Cnr genes were initially found [7] to be part of a multi-gene family, with the additional interesting feature that when genomic DNA was hybridized with a 5′ Cnr cDNA probe, approximately 20 different genes were recognized, whereas a 3′ Cnr cDNA probe detected only three or so genes. This indicated that the 5′ coding portion of the Cnr cDNA may have originated from a diverse locus, whereas the 3′ portion had a simpler and clearly different genomic origin. This observation was further remarkable in that multiple Cnr genes appeared to reside in the same chromosomal region, suggesting a rather localized and perhaps tandem gene organization, and hinting at interesting mechanisms of gene regulation, likely including mRNA splicing or even DNA rearrangement.
Organization of human protocadherin genes
Wu and Maniatis [8] have now analysed the human counterpart of the protocadherin genes, including the Cnrs. By a combination of genomic database analyses and cDNA cloning, they identified a multigene family, subgroups of which encoded proteins homologous to the mouse protocadherins and cadherin-related neuronal receptors. They identified approximately 52 genes, spread over nearly 700 kilobases of the genome (Figure 2a ). Within this locus, which was mapped to chromosome 5q31, three subfamilies of 'protocadherin human' (Pcdh) genes -α, β and γ -were identified.
Most remarkable was the organization of genes within each subfamily. In the 5′ -upstream -part of each group, multiple, homologous 'variable' gene segments were found to be tandemly arrayed. The last of these was followed by three small exons encoding a single constant region, the cytoplasmic portion of the protein. The constant regions encoded by Pcdhα and Pcdhγ differ in sequence; for Pcdhβ, the constant region exons have not yet been identified, but it seems likely that they will eventually be found. Each variable gene segment encoded the remaining -extracellular and transmembrane -domains of the protocadherin. At some level -RNA splicing or DNA recombination -the coding sequences of the variable segment and the constant region exons are joined, so that the final mRNA encodes a full protocadherin protein. This organization can explain why, in the mouse, a 5′ Cnr probe recognized a much larger group of gene segments than a 3′ Cnr probe. It is quite different from the more conventional organization of the genes encoding the classical cadherins, such as P-cadherin or L-CAM [14] .
Similarities to antigen receptor genes
This general organization of tandemly arranged gene segments is reminiscent of the distributed germline organization of antigen receptor genes (Figure 2b ). So far, physiological somatic DNA rearrangements have been demonstrated only in the immune system, where they bring together the gene segments needed to produce mature genes coding for immunoglobulin heavy and light chains [15] and the T-cell receptor [16] . In the immune system, this process of recombination generates the huge diversity of receptors needed to guard against similarly diverse foreign antigens. Taking the immunoglobulin heavy chain locus as an example, the component segments -V ('variable'), D ('diversity') and J ('joining') -are brought together by specific 'V(D)J recombination' reactions; multiple exons coding for the protein's constant region domains are located downstream of the J segments [17] . V(D)J recombination requires cis elements, known as 'recognition signal sequences', and the specific recombinase proteins, Rag1 and Rag2 [18] .
A number of the key hallmarks of V(D)J recombination are clearly not shared by the protocadherin loci. The entire protocadherin variable region is encoded by a single exon, so any genetic rearrangement must involve joining of a variable gene segment to the constant region exons. In the case of the antigen receptor genes, this particular joining event involves either splicing or a non-site-specific DNA rearrangement (see below). Any sequences significantly similar to the recognition signal sequences of the antigen receptor genes should have been recognizable; Wu and Maniatis [8] did not find any such sequences within the protocadherin loci, though as they noted this does not rule out the presence of a different type of cis-acting recognition sequence for recombination.
The possibility that a site-specific DNA rearrangement of the kind that occurs in the immune system operates at the protocadherin loci is thus a remote one. As alternatives, Wu and Maniatis [8] have suggested three different types of RNA splicing mechanism that could bring together the protocadherin coding sequences. As an aside, it seems likely, given the availability of DNA sequence data and the sophistication of polymerase chain reaction (PCR) techniques, that any obvious rearrangement at the protocadherin loci would have already been identified. Given these considerations, are there any other aspects of protocadherin genes suggestive of DNA rearrangement?
Gene rearrangement?
Several intriguing aspects of the protocadherins remain for one to ponder. First, the cadherin-related neuronal receptors -generally considered a subfamily of the protocadherins -were first identified by their ability to bind Fyn, which in the immune system interacts with the product of genes that clearly undergo DNA rearrangement -the T-cell receptor [12] . Second, earlier studies suggested that, if DNA rearrangement does occur in the nervous system, it would be of a distinct kind from V(D)J recombination, as although Rag1 has been observed in neurons the requisite Rag2 has not [1, 19, 20] . And third, the genomic organization of the protocadherin lociwith a tandem array of intact variable exons, rather than multiple gene segments that require joining to create complete exons -itself suggests that any kind of DNA rearrangement would be significantly different from V(D)J recombination.
Another type of DNA recombination that operates on the immunoglobulin heavy chain gene is that mediating 'class switching' [21] . Following V(D)J recombination, production of a heavy chain protein involves RNA splicing that joins the variable region exons to either µ or δ constant region exons; subsequent maturation of the B cell bearing the immunoglobulin involves switching to production of a different type of heavy chain, typically an immunoglobulin G with a constant region encoded by γ exons. This class switching involves DNA rearrangement that is not sitespecific. Another type of DNA rearrangement, known for many years as the basis of yeast mating-type switching, but likely to occur in other contexts (such as the chicken immune system), is gene conversion [22] . This process also is not site-specific, but exploits sequence similarity within tandem gene arrays -a condition that does exist at the protocadherin loci.
A very speculative possibility is that one or other, or both, of these mechanisms might be used to produce different combinations of variable and constant exons, and thereby recombining the extracellular adhesion and intracellular signaling specificities in different ways. In the nervous system, where neurons can be very long-lived, a genomic alteration may provide advantages over a reliance on nongenomic ways of controlling gene expression. Classical cadherins interact homophilically. How protocadherins interact in vivo is unclear, but combining extracellular and intracellular domains in different ways could achieve a substantial degree of combinatorial complexity that could be very useful for the nervous system. All of these musings lead back to the original problem of identifying a rearrangement locus. It might prove fruitful to investigate whether non-homologous end joining is relevant to protocadherin expression, though it should be noted that deficiency of XRCC4 or DNA ligase IV [2, 3] causes neuronal death and embryonic lethality, whereas deficiency of Fyn, which signals downstream of the cadherin-related neuronal receptors at least, causes non-lethal behavioral abnormalities [11] . One could, however, imagine that protocadherins interact with a range of other intracellular signaling molecules that can partially rescue the Fyn deficiency, but not the more pervasive defects caused by a loss of non-homologous end joining capacity. If protocadherin genes do undergo DNA rearrangement, it should not take long to demonstrate the fact. One should not be too surprised, however, if strange beasts still remain to be encountered. 
